Hunan

Hunan Er-Kang Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and large-scale production of pharmaceutical excipients, active pharmaceutical ingredients (APIs), and finished drug products. The company is globally recognized for its innovation in starch-based capsules, providing a plant-derived alternative to traditional gelatin capsules. Er-Kang operates extensive manufacturing facilities that adhere to international GMP standards, supplying products to both domestic and international markets. Their business model integrates the entire value chain from raw material processing to the distribution of finished dosage forms.